# Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry

> **NCT04712175** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 250 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Nasopharyngeal sampling
- **DIAGNOSTIC_TEST:** Saliva sampling

## Key facts

- **NCT ID:** NCT04712175
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-04
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-12-18
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2023-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04712175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04712175, "Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04712175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*